creating long term value through health engagement
play

Creating long-term value through health engagement Bruce D. - PowerPoint PPT Presentation

Creating long-term value through health engagement Bruce D. Broussard President & Chief Executive Officer Humana Inc. CECP - Strategic Investor Initiative February 27, 2017 Cautionary statement This presentation includes forward-looking


  1. Creating long-term value through health engagement Bruce D. Broussard President & Chief Executive Officer Humana Inc. CECP - Strategic Investor Initiative February 27, 2017

  2. Cautionary statement This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of our executive officers, the words or phrases like "expects," "anticipates," "believes, " "intends," "likely will result," "estimates," "projects" or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the "Risk Factors" section of our SEC filings, as listed below. In making these statements, Humana is not undertaking to address or update these statements in future filings or communications regarding its business or results. In light of these risks, uncertainties and assumptions, the forward-looking events discussed herein might not occur. There also may be other risks that we are unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements. Humana advises investors to read the following documents as filed by the company with the SEC: – Form 10-K for the year ended December 31, 2016; – Form 8-Ks filed during 2017.

  3. About Humana $54 Billion – 2016 Revenues Insurance Services Healthcare Services • Leading position in Medicare Advantage • Humana At Home – ~1 million members (MA) and Part D served o 3.2 million MA members • Humana Pharmacy – 4 th largest o 5 million stand-alone Part D members PBM/mail order services • Primary Care Clinics - 66 fully owned; 79 • One of the leading service providers to joint ventures the military through TRICARE contract o 3.1 million members • Go365 - Proprietary prevention/wellness o Recently awarded East Region program; 3.6 million members Contract expanding to over 6 million members (effective Oct 2017) • Integrated Clinical & Consumer 1.7 million commercial group members Analytics platform • 3

  4. Fast growing healthcare costs are driven by an aging population, growing prevalence of chronic disease combined with a misaligned healthcare system People in U.S. with Chronic disease prevalence, US Federal revenue / chronic disease (M) US population (M) spending, ($T) 120 200 105 171 164 100 157 3 149 141 84 81 150 80 +6% 1.9 2 1.7 60 1.5 100 1.3 37% 1.2 38% 40 1.0 39% 40 35 1 40% 18 39% 38% 50 63% 62% 29 6 20 61% 60% 61% 25 62% 20 17 7 0 0 0 Ages Ages Ages Ages 2016 2018 2020 2022 2024 2026 ’10 ’15 ’20 ’25 ’30 0-19 20-44 45-64 65+ Represents a relatively stable ~45% No chronic conditions Other health programs of the US population Medicare 2+ chronic conditions 1 chronic condition Source: CMS Health Care Enrollment tables ; AHRQ survey data 4

  5. The healthcare industry has an opportunity to move beyond treatment to improving health through managing health and lifestyle Low Severity Medium Severity High Severity Cost Avg. Medical $613 $1,852 $4,059 Claims Source: All data are for 2013, except health metrics, which are for Q2 2014. Member count and cost data: CODA_3626. Non-diabetic progression rate: Clinical 5 Analytics Diabetes Predictive Model. Other progression rates: calculated from Diabetes Opportunity Size Model. Health metrics by severity: CODA_248

  6. The basis for competition is changing rapidly with integration becoming critical to success Focus on actuarial value: • Medical cost management • Basic clinic capabilities Industry evolution will result in aligned payments, a less complex healthcare system and more engaged individuals in health 6

  7. Our health-focused business model

  8. Essential to capitalizing on the growing demand is driving engagement in clinical programs QUALITY MEMBERSHIP GROWTH … is driven by AFFORDABLE PRODUCTS …which is enabled by CLINICAL PROGRAMS EXPERIENCE PRODUCTIVITY …and results in a strong brand 8 8

  9. ‏ We focus on five key areas of healthcare to drive effective engagement Behavior Preventio Primary Home Pharmac al n care healt y & wellness h health Growing membership, increasing engagement and broadening clinical programs drive the expansion of our Healthcare Services businesses 9

  10. Ending Medicare membership, in millions 10% 5-year ~5.3 5.0 Combined CAGR 4.6 4.0 3.3 ~3.3 3.2 3.2 3.1 2.9 2.5 2.3 2012 2013 2014 2015 2016 2017E Medicare Advantage (7% 5-yr CAGR) PDP (11% 5-yr CAGR) 10

  11. Consolidated revenues, in billions 7% 5-year CAGR ~$54.0 $54.4 $54.3 $48.5 $41.3 $39.1 2012 2013 2014 2015 2016 2017E 11

  12. Earnings per diluted common share GAAP Adjusted (non-GAAP) $12.00 $20.00 $10.94 $10.90 $16.75 $9.61 $9.40 $9.00 $15.00 $8.29 $7.79 7% 5-year CAGR $6.00 $10.00 $8.44 $7.73 $7.47 $7.36 $3.00 $5.00 $4.07 $0.00 $0.00 2012 2013 2014 2015 2016 2017E 2012 2013 2014 2015 2016 2017E A reconciliation of GAAP to Adjusted EPS is included in this slide presentation The company has included financial measures in this presentation that are not in accordance with Generally Accepted Accounting Principles (GAAP). Management believes that these measures, when presented in conjunction with the comparable GAAP measures, are useful to both management and its investors in analyzing the company’s ongoing business and operating performance. Consequently, management uses these non-GAAP financial measures as indicators of the company’s business performance, as well as for operational planning and decision making purposes. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial 12 measures prepared in accordance with GAAP. All financial measures in this presentation are in accordance with GAAP unless otherwise indicated.

  13. Capital deployment will focus on growing our clinical capabilities  Returning Capital to Shareholders  Returning capital to shareholders  Share repurchase program of $1.5 billion ASR in 1Q 2017  ~$500 million in additional repurchases during remainder of year  Cash dividend raised by approximately 40 percent in 1Q 2017  Acquisitions/Capital Investment  Home health capabilities in care delivery  Owned primary care clinics, joint ventures and population health technology  Behavioral health capabilities  Small pharmacy dispensing capabilities in clinics / physician offices 13

  14. Our health-focused business model Measuring the health of is what drives our purpose … the communities we serve Our Bold Goal The communities we serve will be 20% healthier by 2020 because we make it easy for people to achieve their best health 14

  15. …which includes our commitment to our associates Health Impact • 9% decreased number of health risks • 42% eliminated risks & improved health • 37% returned to normal blood pressure • 20% reduced pre-diabetes prevalence Volunteerism • ~33% actively engaged in volunteerism 90 th Reducing ‘unhealthy days’ Associate engagement compared to other Fortune 100 global companies 15

  16. …and to our communities Our consumer-focused Integrated Care Delivery strategy 16

Recommend


More recommend